Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.
J Cyst Fibros
; 22(4): 656-664, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37121795
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Cystic Fibrosis
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
J Cyst Fibros
Year:
2023
Document type:
Article